Revascularization in Nonagenarian Patients With Critical Lower Limb Ischaemia

Hospital Universitario Getafe53 enrolled

Overview

The rise in life expectancy implies an increased number of nonagenarian patients who need evaluation for critical lower limb ischaemia (CLI). The study goal is to evaluate whether revascularization techniques in these patients fulfill a set of security and efficacy criteria generated from surgical results in a validated historical cohort.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Critical Limb Ischemia

Eligibility

Sex: ALLMin age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients suffering from Critical Limb Ischemia aged 90 year-old or above Exclusion Criteria: \-

Outcomes

Primary Outcomes

Incidence at 30 days of major adverse cardiovascular events (MACE)

Incidence at 30 days of major adverse cardiovascular events (MACE): stroke, myocardial infarction or death by cardiovascular cause, in percentage.

Time frame: 30 days after the procedure

Incidence at 30 days of major adverse limb events (MALE)

Incidence at 30 days of major adverse limb events (MALE): limb acute ischemia or amputation, in percentage.

Time frame: 30 days after the procedure

Incidence at 30 days of limb major amputations (MA)

Incidence at 30 days of limb major amputations (MA), in percentage.

Time frame: 30 days after the procedure

Secondary Outcomes

Limb salvage (LS)

Percentage of revascularized limb which do no require major amputation at 12 months

Time frame: 12 months after the procedure

Survival

Percentage of patients alive at 12 months

Time frame: 12 months after the procedure

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.